🏃 Another big run for Weight Watchers

...and YES they're still in business                                                                                                                                                                                                                                                                                                                                                                                                                 March 08, 2023 | [Read Online]( Good day, 360! Here are our top 3 investing ideas today. These setups look primed! Be the best prepared investor on the Street! FRTX - Over 50% higher this morning after announcing Phase 1 success RIGL - Gapping 30% higher after crushing earnings estimates WW - Weight Watchers is a 2nd day play, closes up 79% after Sequence, Weekend Health acquisition Ever wanted to learn options trading? Don’t know where to start? How about… 💥One trade – Once a day???💥 Taught by someone with possibly the HIGHEST Win Rate on Wall St??? 👉 See his results for yourself → [Jeff Williams’ Trading Journal](… 👉 Read his reviews for yourself → [TrustPilot Reviews](… 👉 And judge for yourself if [Market Navigator]( is right for you! If you want to be the next BOB, then [CLICK HERE](... And save $1000 on JW's Flagship Options Trading Service – [Expiring Friday!]( 🦸🏽 You got this and JW is here to help 🦸🏽 FRTX - Over 50% higher this morning after announcing Phase 1 success Fresh Tracks Therapeutics announced topline results from its phase 1 study of its oral drug FRTX-02 which met its primary endpoint for daily oral treatment for atopic dermatitis and other autoimmune diseases. The $3.05 area has been resistance in the after-hours and should be an important pivot point today. Above it, the first major target for Bulls would be the pre-market high of $3.33. Above that there is potential resistance at $3.50, $4 and then $4.64. Below $3.05 there is potential support at $2.80 and then $2.60. Below that, targets to the downside are $2.50, $2 and then a gap fill to $1.83. RIGL - Gapping 30% higher after crushing earnings estimates In the after-hours yesterday, RIGL Pharmaceuticals reported Q4 EPS of $0.01 vs -$0.09 estimated. Revenue for the quarter came in at $51.3M vs the $36.52M consensus. The market LOVED the huge beat and surprise profit, and the stock is gapping over 30% higher on the numbers this morning. $1.89 was resistance in the after-hours which then acted as support in the pre-market and should be an important pivot point today. Above that the first major target for Bulls would be the pre-market high of $2.23. Potential resistance levels above that are at $2.40, $2.60, $2.70 and then $2.90. Below $1.89 there is potential support at $1.70-$1.73, $1.60 and then a gap to fill at $1.47. WW - Weight Watchers is a 2nd day play, closes up 79% after Sequence, Weekend Health acquisition Weight Watchers International (WW) missed earnings estimates by reporting Q4 sales of $223.9 million vs $224.53 million expected and issued worse than expected Q1 guidance of Q1 revenue of ~$235million vs $243.89 million expected. However, the company also announced that it would acquire Sequence, Weekend Health for $106 million and the market responded positively to the telehealth company acquisition. WW has a history of some big runs, and after selling off over 90% from 2021 levels yesterday buyers finally took control. $6.40 acted as support yesterday and should be an important pivot point today. Above it, the first target for bulls would be yesterday’s high of $7.07. Potential resistance higher is at $7.40, $7.80, $8.20 and then $9. Below $6.40 there is potential support at $5.90, $5.70. Further targets to the downside are at $5, $4.60, $4.30 and then $4. Economic Calendar (EST) 7:00am MBA mortgage applications 8:15am Employment report 10:00am JOLTS 10:00am Fed Powell speaks 10:30am EIA Petroleum report Earnings for Today (After Market) ADES, ASAN, ASRT, BFRI, BGSF, CDXC, CLLS, CNFR, DADA, ECOR, EOLS, ESTE, FFIE, FOSL, GLRE, GPRK, GWRS, HDSN, IDT, KLXE, KRMD, LDI, LMB, LOMA, MDB, METC, MIRM, MLR, NAPA, NDLS, NEPH, ONL, OPRX, PFIE, QNRX, RBT, RDVT, REPX, SALM, SLNG, SMRT, SONX, SOVO, SPIR, STR, TACT, TCON, TIPT, USIO, VET, VSEC, VTOL Top Headlines INTC Intel Wants $5 Billion More From Germany for a Chip Plant -Bloomberg GVA: Granite Construction Awarded Contract for Ave J Interchange Improvements in Lancaster, California DBVT: DBV Technologies Announces First Patient Screened in VITESSE Phase 3 Clinical Trial in Peanut-Allergic Children 4 – 7 Years Old ROC: ROC Energy Acquisition Corp. Confirms Funding and Second Extension of Deadline to Complete Initial Business Combination FITB Fifth Third Announces Acquisition of Big Data Healthcare, a Payments Company Serving National Health Systems, Physicians AAL DAL American Airlines prepared to match Delta's pilot pay rates -CEO MESO FDA Accepts Mesoblast’s Resubmission of the Biologic License Application for Remestemcel-L In Children with Steroid-Refractory Acute Graft Versus Host Disease as a Complete Response and Sets Goal Date of August NSC: A Norfolk Southern train conductor and former local rail union leader was killed in a crash just days after a second major derailment in Ohio. @Alex_Presha reports as the NTSB opens a special investigation into the railway company’s safety practices. ABC RIVN Rivian Automotive, Inc. Prices $1.3 Billion Green Convertible Senior Notes Offering MYNZ Mainz Biomed Launches Number of Educational Events in Germany to Raise Awareness for CRC Screening and Early Detection NOVV Nova Vision Acquisition Corp. Announces Extension of Combination Period and Additional Contribution to Trust Account to Extend Combination Period to April 10, 2023 AMPH Amphastar Pharmaceuticals Receives FDA Approval for Naloxone Hydrochloride Nasal Spray 4mg PLTR signs $99.6 mln deal with U.S. State Department F Ford Offers Discounts For Mustang Mach-E Electric SUVs In China TSLA Tesla Inc Shares Fall 0.8% in Pre-Market Trading Following Berenberg Downgrade to 'Hold' and China's Passenger Car Sales Data Release President Biden to propose 5.2% federal pay increase - Washington Post SHLS: Shoals Technologies Group, Inc. Announces Pricing of Secondary Offering of 24,501,650 Shares of Class A Common Stock by Selling Stockholders -- Priced @$24.70 CDTX: Closing of Public Offerings of Common Stock and Preferred Stock and Full Exercise of Underwriter’s Option to Purchase Additional Shares in Public Offering of Common Stock SAGE BIIB: Sage Therapeutics and Biogen Share Update on FDA Advisory Committee for Zuranolone PERF: Perfect Corp. Launches Brand New AR 3D Viewer and 3D Authoring Tool to Elevate Virtual Try-On Shopping Experience and Simplify Ring and Watch SKU creation HNI to acquire Kimball International (KBAL) for $485 million in cash and stock PLTR: Department of State Selects Palantir to Modernize Data Management for the Bureau of Medical Services TLSA Tiziana Life Sciences Announces Publication in Proceedings of the National Academy of Sciences (PNAS) Illustrating the Immunological Basis of the Mechanism of Action for Intranasal Foralumab CSTL Recommendations by Expert Consensus Panel Relating to Risk-Stratification Tests and Tools for Use in Cutaneous Melanoma Have Been Adopted as an Official Policy Recommendation of the National Society for Cutaneous Medicine BBIO BridgeBio Pharma Announces Pricing of Public Offering of Common Stock of 8.82 Million Shares at $17 Each AVIR: New Data Showcasing Favorable Profile of Bemnifosbuvir for Treatment of COVID-19 and Hepatitis C to be Presented at 2023 International Conference on Antiviral Research GFGD: ZeroNox, a Leader in Off-Highway Electrification of Commercial and Industrial Vehicles, to Become First Public Company of its Kind, Through Merger with The Growth for Good Acquisition Corporation ALGM: Allegro MicroSystems Announces Industry’s First ASIL C Safety Rated Field Current Sensor for Electric Vehicle Powertrain Systems TSLA US investigates 120,000 Tesla Model Y Vehicles for steering wheels that can fall off: AP ATHE Alterity Therapeutics Enrolls First Patient in Italy in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy MNTS Momentus (NASDAQ: MNTS) Vigoride-6 Spacecraft Arrives at SpaceX Launch Site To Your Success! Please see disclosures below. Questions or concerns about our products? Email [Support@360wallstreet.io]( © Copyright 2022, RagingBull DISCLAIMER To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [( FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of []( or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers. [RagingBull.com](, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with [RagingBull.com](, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, [RagingBull.com](, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. [tw]( Update your email preferences or unsubscribe [here]( © 360wallstreet 62 Calef Hwy. #233 lee, NH 03861, United States [[beehiiv logo]Powered by beehiiv](